1501 Stock Overview
Shanghai Kindly Medical Instruments Co., Ltd.
Shanghai Kindly Medical Instruments Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$26.70|
|52 Week High||HK$34.85|
|52 Week Low||HK$10.80|
|1 Month Change||20.27%|
|3 Month Change||69.20%|
|1 Year Change||-19.46%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-1.11%|
Recent News & Updates
Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year
Shanghai Kindly Medical Instruments Co., Ltd. ( HKG:1501 ) is reducing its dividend to HK$0.32 on the 20th of June. The...
|1501||HK Medical Equipment||HK Market|
Return vs Industry: 1501 exceeded the Hong Kong Medical Equipment industry which returned -53.4% over the past year.
Return vs Market: 1501 exceeded the Hong Kong Market which returned -20.5% over the past year.
|1501 Average Weekly Movement||7.3%|
|Medical Equipment Industry Average Movement||8.4%|
|Market Average Movement||6.6%|
|10% most volatile stocks in HK Market||12.8%|
|10% least volatile stocks in HK Market||3.2%|
Stable Share Price: 1501 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 1501's weekly volatility (7%) has been stable over the past year.
About the Company
Shanghai Kindly Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers interventions products, which includes guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire used in percutaneous transluminal angioplasty (PTA) surgical procedures; angiography catheter used to inject and infuse contrast media and fluid; and Y-connector pack used in PTCA surgery.
Shanghai Kindly Medical Instruments Fundamentals Summary
|1501 fundamental statistics|
Is 1501 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|1501 income statement (TTM)|
|Cost of Revenue||CN¥188.93m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.85|
|Net Profit Margin||30.76%|
How did 1501 perform over the long term?See historical performance and comparison
1.1%Current Dividend Yield
Is 1501 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1501?
Other financial metrics that can be useful for relative valuation.
|What is 1501's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 1501's PE Ratio compare to its peers?
|1501 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
1763 China Isotope & Radiation
9997 Kangji Medical Holdings
2276 Shanghai Conant Optical
1066 Shandong Weigao Group Medical Polymer
1501 Shanghai Kindly Medical Instruments
Price-To-Earnings vs Peers: 1501 is expensive based on its Price-To-Earnings Ratio (27x) compared to the peer average (14.8x).
Price to Earnings Ratio vs Industry
How does 1501's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price-To-Earnings vs Industry: 1501 is expensive based on its Price-To-Earnings Ratio (27x) compared to the Hong Kong Medical Equipment industry average (16.8x)
Price to Earnings Ratio vs Fair Ratio
What is 1501's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||27x|
|Fair PE Ratio||17.6x|
Price-To-Earnings vs Fair Ratio: 1501 is expensive based on its Price-To-Earnings Ratio (27x) compared to the estimated Fair Price-To-Earnings Ratio (17.6x).
Share Price vs Fair Value
What is the Fair Price of 1501 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 1501 (HK$26.7) is trading below our estimate of fair value (HK$63.93)
Significantly Below Fair Value: 1501 is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Shanghai Kindly Medical Instruments forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score6/6
Future Growth Score 6/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1501's forecast earnings growth (26.2% per year) is above the savings rate (1.6%).
Earnings vs Market: 1501's earnings (26.2% per year) are forecast to grow faster than the Hong Kong market (16.8% per year).
High Growth Earnings: 1501's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1501's revenue (27.7% per year) is forecast to grow faster than the Hong Kong market (10.1% per year).
High Growth Revenue: 1501's revenue (27.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1501's Return on Equity is forecast to be high in 3 years time (24.6%)
Discover growth companies
How has Shanghai Kindly Medical Instruments performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1501 has a high level of non-cash earnings.
Growing Profit Margin: 1501's current net profit margins (30.8%) are lower than last year (33.9%).
Past Earnings Growth Analysis
Earnings Trend: 1501's earnings have grown significantly by 21.8% per year over the past 5 years.
Accelerating Growth: 1501's earnings growth over the past year (17.8%) is below its 5-year average (21.8% per year).
Earnings vs Industry: 1501 earnings growth over the past year (17.8%) underperformed the Medical Equipment industry 35.4%.
Return on Equity
High ROE: 1501's Return on Equity (9.8%) is considered low.
Discover strong past performing companies
How is Shanghai Kindly Medical Instruments's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 1501's short term assets (CN¥858.4M) exceed its short term liabilities (CN¥153.2M).
Long Term Liabilities: 1501's short term assets (CN¥858.4M) exceed its long term liabilities (CN¥30.4M).
Debt to Equity History and Analysis
Debt Level: 1501 is debt free.
Reducing Debt: 1501 has not had any debt for past 5 years.
Debt Coverage: 1501 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 1501 has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Shanghai Kindly Medical Instruments's current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 1501's dividend (1.13%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.87%).
High Dividend: 1501's dividend (1.13%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.36%).
Stability and Growth of Payments
Stable Dividend: 1501 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 1501 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: 1501 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: 1501 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dongke Liang (44 yo)
Dr. Dongke Liang has been Executive Chairman of the Board at Shanghai Kindly Medical Instruments Co., Ltd. since April 26, 2016 and also has been its General Manager since June 30, 2010 and Executive Direc...
Experienced Management: 1501's management team is considered experienced (3.3 years average tenure).
Experienced Board: 1501's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Shanghai Kindly Medical Instruments Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Shanghai Kindly Medical Instruments Co., Ltd.
- Ticker: 1501
- Exchange: SEHK
- Founded: 2006
- Industry: Health Care Supplies
- Sector: Healthcare
- Implied Market Cap: HK$4.486b
- Shares outstanding: 168.00m
- Website: https://www.kdl-int.com
Number of Employees
- Shanghai Kindly Medical Instruments Co., Ltd.
- No. 925 Jin Yuan Yi Road
- Block 2
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/08 00:00|
|End of Day Share Price||2022/08/08 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.